Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols

Rationale: lactose is the only FDA-approved carrier for dry powder inhaler (DPI) formulations in the US. Lactose carrier-based DPI products are contraindicated in patients with a known lactose allergy. Hence, inhaler formulations without lactose will benefit lactose allergic asthmatics. Objectives:...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:RSC Adv
Huvudupphovsmän: Muralidharan, Priya, Mallory, Evan K., Malapit, Monica, Phan, Hanna, Ledford, Julie G., Hayes, Don, Mansour, Heidi M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: The Royal Society of Chemistry 2020
Ämnen:
Chemistry
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689944/
https://ncbi.nlm.nih.gov/pubmed/33391731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0ra07203f
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk